Cas no 185678-56-2 (1-Indan-1-yl-piperazine)
1-Indan-1-yl-piperazine Chemical and Physical Properties
Names and Identifiers
-
- Piperazine,1-(2,3-dihydro-1H-inden-1-yl)-
- 1-(2,3-dihydro-1H-inden-1-yl)piperazine
- 1-Indan-1-yl-piperazine
- indanyl-piperazine
- EN300-1858619
- 185678-56-2
- 1-(Indan-1-yl)piperazine
- CS-0270371
- Indanylpiperazin
- DTXSID30445703
- A812973
- MFCD06796399
- PWOUAMWQYHOLIB-UHFFFAOYSA-N
- AKOS010287484
- SCHEMBL1307195
- 1-INDAN-1-YL-PIPERAZINE >98%
- G30941
-
- MDL: MFCD06796399
- Inchi: 1S/C13H18N2/c1-2-4-12-11(3-1)5-6-13(12)15-9-7-14-8-10-15/h1-4,13-14H,5-10H2
- InChI Key: PWOUAMWQYHOLIB-UHFFFAOYSA-N
- SMILES: N1(CCNCC1)C1C2C=CC=CC=2CC1
Computed Properties
- Exact Mass: 202.14700
- Monoisotopic Mass: 202.146998583g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 15
- Rotatable Bond Count: 1
- Complexity: 211
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 1.5
- Topological Polar Surface Area: 15.3?2
Experimental Properties
- Boiling Point: 92°C/.08mm
- PSA: 15.27000
- LogP: 1.84580
1-Indan-1-yl-piperazine Customs Data
- HS CODE:2933599090
- Customs Data:
China Customs Code:
2933599090Overview:
2933599090. Other compounds with pyrimidine ring in structure(Including other compounds with piperazine ring on the structure. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
1-Indan-1-yl-piperazine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Fluorochem | 024885-1g |
1-Indan-1-yl-piperazine |
185678-56-2 | 98% | 1g |
£100.00 | 2022-02-28 | |
| Fluorochem | 024885-5g |
1-Indan-1-yl-piperazine |
185678-56-2 | 98% | 5g |
£400.00 | 2022-02-28 | |
| Fluorochem | 024885-10g |
1-Indan-1-yl-piperazine |
185678-56-2 | 98% | 10g |
£680.00 | 2022-02-28 | |
| TRC | I655780-50mg |
1-Indan-1-yl-piperazine |
185678-56-2 | 50mg |
$ 50.00 | 2022-06-04 | ||
| TRC | I655780-100mg |
1-Indan-1-yl-piperazine |
185678-56-2 | 100mg |
$ 70.00 | 2022-06-04 | ||
| TRC | I655780-500mg |
1-Indan-1-yl-piperazine |
185678-56-2 | 500mg |
$ 250.00 | 2022-06-04 | ||
| Ambeed | A799804-1g |
1-(2,3-Dihydro-1H-inden-1-yl)piperazine |
185678-56-2 | 97% | 1g |
$241.0 | 2024-07-28 | |
| abcr | AB305076-1 g |
1-Indan-1-yl-piperazine, 98%; . |
185678-56-2 | 98% | 1g |
€164.20 | 2023-04-26 | |
| abcr | AB305076-5 g |
1-Indan-1-yl-piperazine, 98%; . |
185678-56-2 | 98% | 5g |
€556.10 | 2023-04-26 | |
| abcr | AB305076-10 g |
1-Indan-1-yl-piperazine, 98%; . |
185678-56-2 | 98% | 10g |
€922.50 | 2023-04-26 |
1-Indan-1-yl-piperazine Related Literature
-
Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
-
Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
-
Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
-
Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
-
Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
Additional information on 1-Indan-1-yl-piperazine
1-Indan-1-yl-piperazine: A Comprehensive Overview
1-Indan-1-yl-piperazine (CAS No. 185678-56-2) is a fascinating compound that has garnered significant attention in the fields of organic chemistry, pharmacology, and materials science. This compound is a derivative of piperazine, a six-membered ring containing two nitrogen atoms, which is widely used as a building block in drug design and material synthesis. The indan ring system, fused with the piperazine core, introduces unique electronic and steric properties that make this compound particularly interesting for various applications.
Recent studies have highlighted the potential of 1-indan-1-yl-piperazine in drug discovery, particularly in the development of kinase inhibitors and GPCR modulators. For instance, researchers have explored its role in targeting specific protein kinases involved in cancer progression. The indan moiety has been shown to enhance the compound's ability to bind to these targets, making it a promising lead for anti-cancer therapies. Furthermore, its structural flexibility allows for easy modification, enabling chemists to optimize its pharmacokinetic properties for better bioavailability.
In the realm of materials science, 1-indan-1-yl-piperazine has been investigated as a precursor for the synthesis of advanced polymers and coordination polymers. Its nitrogen-rich structure makes it an ideal candidate for forming stable metal-ligand interactions, which are crucial in creating porous materials with applications in gas storage and catalysis. Recent breakthroughs in this area have demonstrated its potential in creating highly selective membranes for carbon dioxide capture, a critical technology in combating climate change.
The synthesis of 1-indan-1-yl-piperazine typically involves a multi-step process that combines traditional organic synthesis techniques with modern catalytic methods. One common approach involves the nucleophilic substitution of an appropriately substituted indane derivative with piperazine under controlled conditions. Recent advancements in catalysis have enabled higher yields and improved purity levels, making this compound more accessible for large-scale applications.
From a pharmacological perspective, 1-indan-1-yl-piperazine exhibits interesting bioactivity profiles that make it a valuable tool in drug discovery. Preclinical studies have shown that it possesses moderate inhibitory activity against several enzymes implicated in neurodegenerative diseases, such as acetylcholinesterase and butyrylcholinesterase. These findings suggest its potential as a lead compound for developing treatments for Alzheimer's disease and related conditions.
In conclusion, 1-indan-1-yl-piperazine (CAS No. 185678-56-2) is a versatile compound with a wide range of applications across multiple disciplines. Its unique chemical structure, combined with recent advancements in synthesis and application development, positions it as a key player in both academic research and industrial innovation. As ongoing studies continue to uncover new potentials for this compound, its role in shaping future technologies and therapeutic interventions is likely to grow significantly.
185678-56-2 (1-Indan-1-yl-piperazine) Related Products
- 75463-35-3(1-Piperidineethanamine,N-(1,2,3,5,6,7-hexahydro-s-indacen-1-yl)-, hydrochloride (1:2))
- 187221-94-9(4-(2,3-dihydro-1H-inden-1-yl)-1-Piperazineethanamine)
- 181034-50-4(1H-Indeno[1,2-b]pyrazine,2,3,4,4a,9,9a-hexahydro-1-methyl-, trans- (9CI))
- 181034-51-5(1H-Indeno[1,2-b]pyrazine,2,3,4,4a,9,9a-hexahydro-1-methyl-, cis- (9CI))
- 627522-38-7(1,2-Ethanediamine, N-(2,3-dihydro-1H-inden-1-yl)-N'-undecyl-)
- 17910-40-6(1-methyl-4-(6,7,8,9-tetrahydro-5H-benzocyclohepten-5-yl)-piperazine)
- 58350-22-4(1,2,3,4,6,11,12,12a-octahydro-Pyrazino[1,2-b][2]benzazepine)
- 187221-31-4(1-(1,2,3,4-tetrahydronaphthalen-1-yl)piperazine)
- 627526-23-2(1,2-Ethanediamine, N-(2,3-dihydro-1H-inden-1-yl)-N'-(4-phenylbutyl)-)
- 1067660-16-5(4-(2,3-dihydro-1H-inden-1-yl)-1-Piperazineacetonitrile)